Video Experimental Relacionado
Updated: Aug 7, 2026
03:05
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Informar a los médicos sobre nuevos tratamientos prometedores para enfermedades graves
1Los Angeles Times, Calif.
JAMA
|April 18, 1990
Resumen
Los médicos necesitan una mejor información sobre los nuevos tratamientos para enfermedades graves. La mejora de los canales de comunicación asegura actualizaciones oportunas y detalladas para una mejor atención al paciente.
Área de la Ciencia:
- Las comunicaciones médicas de las comunicaciones médicas.
- Difusión de Información de Salud Difusión de Información de Salud
- Práctica clínica La práctica clínica es la práctica clínica.
Sus antecedentes:
- Los médicos reciben información sobre nuevos tratamientos a través de canales no convencionales como los comunicados de prensa.
- Estos canales difunden la información rápidamente, a menudo antes de la publicación revisada por pares.
- Las comunicaciones no convencionales actuales carecen de suficiente detalle para la evaluación del médico.
Objetivo del estudio:
- Identificar las limitaciones en la comunicación actual de los médicos con respecto a nuevos tratamientos.
- Proponer estrategias para mejorar la difusión de los avances terapéuticos.
- Mejorar la capacidad de los médicos para evaluar y comunicar información de tratamiento a los pacientes.
Principales métodos:
- Análisis de las prácticas actuales de difusión de información para nuevas terapias.
- Revisión de las brechas de comunicación existentes para los proveedores de atención médica.
- Formulación de recomendaciones para mejorar la accesibilidad de la información.
Principales resultados:
- Las comunicaciones no convencionales a menudo carecen de la profundidad necesaria para la toma de decisiones clínicas.
- Existen retrasos significativos entre los anuncios iniciales y la disponibilidad de datos revisados por pares.
- Los médicos requieren información más detallada y accesible para guiar el cuidado del paciente.
Conclusiones:
- Mejorar las comunicaciones no convencionales con más datos es crucial.
- Se necesita una mayor accesibilidad a la información de la Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés).
- Las presentaciones tempranas de revistas, revisiones aceleradas y recursos en línea pueden mejorar el conocimiento del médico.
- Los médicos mejor informados pueden mejorar los resultados para los pacientes con enfermedades graves.
Más Videos Relacionados
08:26Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Videos de Conceptos Relacionados
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...